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1. Introduction
A wide variety of molecules including natural products,
peptides, and synthetic small compounds exhibit their biological 
activities through specific interactions with target 
biomacromolecules. Proteins including enzymes, receptors, and 
ion channels represent the major group of these targets. 
Identification of unknown protein targets that interact with 
biologically active ligands has become indispensable in the fields 
of chemical biology and drug development; however, this 
research approach is time-consuming and laborious. The target 
identification comprises a sequence of processes: (1) fishing a 
target using a biologically active ligand as bait; (2) enrichment of 
the hooked target; and (3) sequence analysis of the target by 
Edman degradation or mass spectrometry (MS).1 For the first 
step, photo-affinity labeling which allows bait to be covalently 
bounded to the corresponding target upon photo-irradiation has 
significant use, because of the potential applicability to low 
affinity ligand-target pairs.1a,b,2 The hooked target is then linked 
with a biotinylated linker molecule for facile purification by 
streptavidin beads using the biotin-streptavidin interaction.1,3 The 
immobilized target is subsequently released from the beads for 
sequence analysis by attenuating the biotin-streptavidin 
interaction. The high affinity of the biotin-streptavidin interaction 
(Kd = 10–15 M),4 however, hampers liberation of the target from 
the beads. An alternative to liberate the target is the use of a 
cleavable linker between the bait and biotin.5 This approach 
enables efficient elution of the target protein from the beads via 
the linker cleavage, but contamination owing to the presence of 
non-target proteins sometimes hampers identification of the 
target.6 The cleavage under mild conditions and generation of an 
orthogonal functional group not seen in proteins, therefore, has 
been desired in this procedure. The orthogonal functional group 
enables chemoselective labeling of the target protein by an 
isotopic or fluorescent tag. That facilitates discrimination of the 
target from contaminated proteins by MS using isotopic tag or 
SDS-PAGE using fluorescent tag. 
We previously developed a traceable linker as an advanced 
cleavable linker that enables selective labeling of the target 
protein after elution from the streptavidin beads via the linker 
cleavage (Figure 1a).7,8 A key component of the traceable linker 
is a stimulus-responsive amino acid that possesses a stimulus-
removable protective group (PG) on the phenolic hydroxyl group 
(Figure 1b).9 The stimulus-responsive amino acid induces amide 
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bond cleavage after stimulus-induced removal of the PG and 
subsequent lactonization of a trimethyl lock moiety.10 In a 
previous report, the traceable linker composed of a thiol-
responsive amino acid, in which the PG is a p-
nitrobenzenesulfonyl (pNs) group, was presented (Figure 1a). 
The traceable linker was introduced onto an alkynylated protein 
by click chemistry and then adsorbed onto the streptavidin beads. 
Subsequent addition of a thiol triggered the cleavage of the linker 
to release the protein possessing an aminooxy group. Since the 
aminooxy group can react with an aldehyde chemoselectively,11 
the eluted target protein was selectively labeled with an 
aldehyde-containing labeling reagent even when contaminated 
non-target proteins co-existed. As the thiol was used as the 
cleavage inducer in this system, it is preferable to remove 
endogenous thiols such as glutathione before the use of the thiol-
responsive traceable linker.12 To avoid the risk of unintentional 
cleavage of the traceable linker, in this study, we have developed 
a fluoride-responsive (FR) traceable linker, because there are few 
fluoride ions present in a living body.13 
 
 
Figure 1. Molecular design. (a) Purification and selective labeling of an 
alkynylated protein using a thiol-responsive traceable linker (pNs: p-
nitrobenzenesulfonyl group). (b) A stimulus-responsive amide bond cleavage 
system (PG: protective group that is removable by appropriate stimulus). 
 
2. Results and discussion 
2.1. Synthesis of a FR amino acid 
Preparation of the FR amino acid possessing a fluoride-
removable protective group as the PG of the stimulus-responsive 
amino acid was attempted. A tert-butyldiphenylsilyl (TBDPS) 
group was chosen as the fluoride-removable PG because acid 
treatment is unavoidable for the synthesis of the traceable linker 
and the TBDPS group is relatively acid tolerant compared with 
other trisubstituted silyl protections.14 In this study, Fmoc 
protected derivatives were designed for Fmoc-based solid phase 
peptide synthesis (Fmoc SPPS). We first attempted to synthesize 
silyl ether 1, but introduction of the TBDPS group onto the 
phenolic hydroxyl group of 215 did not proceed (Figure 2). In 
these reactions, recovery of the starting material, removal of the 
Boc group and/or removal of the tert-butyldimethylsilyl (TBS) 
group were observed. We speculated that the direct introduction 
of the TBDPS group onto the phenol is sterically unfavorable and 
steric crowding around the phenol was observed in an energy 
minimized structure of substrate 2 using an MM2 calculation 
(Figure S1). Therefore, preparation of 3 possessing a sterically 
less demanding siloxybenzyl unit, which can be removed via 
fluoride-induced cleavage of the silyl group followed by release 
of the quinone methide, onto the phenol was next examined 
(Scheme 1).16 Starting from phenol 2, it was subjected to the 
modified Mitsunobu reaction with the TBDPS derivative 417 
using N,N,N’,N’-tetramethylazodicarboxamide (TMAD).18 The 
TBS group of 5 was then removed under acidic conditions to 
yield alcohol 6. After stepwise oxidation of the alcohol of 6, the 
Boc group was removed by the use of Ohfune’s protocol,19 
because cleavage of the p-siloxybenzyl group was observed when 
trifluoroacetic acid (TFA) or hydrogen chloride was employed. 
The obtained amine was finally protected with an Fmoc group to 
yield FR amino acid 3.  
 
 
Entry Attempted reaction conditions 
1 TBDPSCl, imidazole, DMF 
2 TBDPSCl, imidazole, DMF, 60 °C 
3 TBDPSOTf, 2,6-lutidine, CH2Cl2 
4 TBDPSCl, LiHMDS, THF 
5 TBDPSCl, NaH, DMF 
6 TBDPSCl, AgNO3, DMF 
7 TBDPSCl, AgNO3, pyridine, 60  °C 
 
Figure 2. Synthetic attempts to prepare FR amino acid 1. (LiHMDS: lithium 
hexamethyldisilazide; TBDPSOTf tert-butyldiphenylsilyl 
trifluoromethanesulfonate) 
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Scheme 1. Reagents and conditions: (i) 4, TMAD, n-Bu3P, toluene, 98%; (ii) 
AcOH, THF, H2O, quant.; (iii) oxalyl chloride, DMSO, Et3N, THF; (iv) 
NaClO2, NaH2PO4, 2-methyl-2-butene, tert-BuOH, acetone, H2O; (v) tert-
butyldimethylsilyl trifluoromethanesulfonate (TBSOTf), 2,6-lutidine, CH2Cl2; 
(vi) FmocOSu, Na2CO3, acetonitrile (MeCN), H2O, 43% (four steps). 
 
 
Scheme 2. Reagents and conditions: (i) 8, HOBt∙H2O, DIC, DMF; (ii) 20% 
(v/v) piperidine in DMF; (iii) 9, HOBt∙H2O, DIC, DMF; (iv) 3, HATU, DIEA, 
DMF; (v) 10, HOBt∙H2O, DIC, DMF; (vi) biotin, HOBt∙H2O, DIC, DMF; 
(vii) TFE/AcOH/CH2Cl2 = 1/1/3 (v/v). 
 
2.2. Preparation of a FR traceable linker 
FR traceable linker 7 was prepared using Fmoc SPPS (Scheme 
2). Release of the linker from the resin using standard TFA 
conditions was not compatible because of acid lability of the 
siloxybenzyl unit. A 2-chlorotrityl resin from which the product 
can be released by treatment with a weak acid was therefore 
suitable for this synthesis and a commercially available amino 
acid-preloaded resin was employed to avoid laborious attachment 
of the first amino acid on the resin. Starting from the glycine-
preloaded 2-chlorotrityl resin, azide derivative 820 and aminooxy 
derivative 921 were incorporated by standard Fmoc SPPS 
conditions using N,N’-diisopropylcarbodiimide (DIC)/1-
hydroxybenzotriazole (HOBt) system. After coupling of FR 
amino acid 3 in the presence of O-(7-azabenzotriazol-1-yl)-
N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU) 
and N,N-diisopropylethylamine (DIEA), miniPEG unit 10 and 
biotin were incorporated using the DIC/HOBt system. The resin 
was finally treated with a 2,2,2-trifluoroethanol 
(TFE)/AcOH/CH2Cl2 cocktail to generate FR traceable linker 7 
without accompanying the deprotection of the siloxybenzyl unit 
(12% all over yield. An HPLC chart of the product is shown in 
Figure S2 in the Supporting Information). 
2.3. Click chemistry, fluoride-induced cleavage, and selective 
labeling of the FR traceable linker with a model peptide 
In this study, alkyne-containing peptide 117 was employed as 
a model of the alkynylated target protein because of ease of 
handling and characterization of products (Figure 3). tert-Butanol 
was used as a cosolvent to dissolve the traceable linker. 
Traceable linker 7 and model peptide 11 in an aqueous tert-
butanol solution were treated with CuSO4 and sodium ascorbate. 
Following a reaction time of 1 h, completion of the coupling and 
production of conjugate 12 in high purity were confirmed by 
HPLC monitoring.  
 
 
Figure 3. Click chemistry of the traceable linker. (a) Reaction of traceable 
linker 7 with model peptide 11. (b) HPLC monitoring of the click chemistry. 
HPLC conditions: Cosmosil 5C18-AR-II analytical column, linear gradient of 
0.1% (v/v) TFA/MeCN in 0.1% (v/v) TFA aq., 5–90% over 30 min. *Non-
peptidic compound. 
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Fluoride-induced cleavage of the linker moiety of peptide 
conjugate 12 followed by the labeling reaction was next 
examined (Figure 4). Conjugate 12 was dissolved in a phosphate 
buffer containing 0.1 M KF, 100 eq. of 2-mercaptoethanesulfonic 
acid sodium salt (MESNa) as a scavenger of quinone methide 
generated via removal of the siloxybenzyl unit, 6 M guanidine 
hydrochloride, and 0.05 mM EDTA (0.2 M phosphate, pH 7.6), 
and the reaction mixture was incubated at 37 °C. The silyl group 
was completely removed after 2 h of the reaction. Following the 
additional 10 h of incubation, intermediate 13 was cleaved to 
generate biotin derivative 14 and aminooxy derivative 15. These 
results suggest that a rate determining step of the reaction is the 
removal of the quinone methide. The reaction mixture was then 
subjected to subsequent labeling without purification. We used 3-
bromobenzaldehyde as the labeling reagent, because the labeled 
compounds can easily be distinguished based on an isotope 
pattern of the MS.6b,22 To the reaction mixture was added 3-
bromobenzaldehyde and the labeling was accomplished within 5 
min. Although 15 possesses a free amino group at the N-terminus 
of the peptide, incorporation of two aldehydes was not observed. 
This result demonstrates that the selective labeling of the 
aminooxy group with the aldehyde was achieved.23 
 
## Figure 4 ## 
 
3. Conclusion 
Preparation of the FR amino acid and its application to the FR 
traceable linker were reported. The traceable linker was 
successfully introduced onto an alkyne-containing model peptide 
using click chemistry, and fluoride-induced cleavage followed by 
selective labeling of the obtained traceable linker-model peptide 
conjugate was achieved. Its application to the isolation and 
selective labeling of alkynylated target proteins is currently 
underway in our laboratory. 
4. Experimental section 
4.1. General methods 
All reactions of small molecules were carried out under a 
positive pressure of argon at room temperature unless otherwise 
noted. For column chromatography, silica gel (KANTO 
KAGAKU N-60) was employed. Mass spectra were recorded on 
a Waters MICROMASS® LCT PREMIER™ or a Bruker 
Esquire200T. NMR spectra were measured using a JEOL 
GSX400 or a JEOL GSX300 spectrometer. For HPLC 
separations, a Cosmosil 5C18-AR-II analytical column (Nacalai 
Tesque, 4.6 × 250 mm, flow rate 1.0 mL/min) or a semi-
preparative column (10 × 250 mm, flow rate 3 mL/min) was 
employed, and eluting products were detected by UV at 220 nm. 
A solvent system consisting of 0.1% (v/v) TFA in H2O (solvent 
A) and 0.1% TFA (v/v) in MeCN (solvent B) was used for HPLC 
elution. IR spectra and optical rotations were measured using a 
JASCO FT-IR 6200 and a JASCO P-2200 polarimeter 
(concentration in g/100 mL), respectively. A melting point was 
determined on a YAMATO-MODEL 20 melting point apparatus 
and was uncorrected. An elemental analysis was performed using 
a J-SCIENCE LAB JM10. 
4.2. Synthesis of FR amino acid derivatives 
4 .2 .1 .   (S) - t er t -butyl  [1 -{ ( ter t -
butyld imethyls i l y l )oxy}-3 -{2- ([4 -{( ter t -
butyld iphenyls i l y l )oxy}benzyl] oxy)-4 ,6 -
d imethylphenyl} -3 -methy lbutan-2-yl] carbamate (5 )  
To a stirred solution of phenol 215 (200 mg, 0.457 mmol), 
benzyl alcohol 417 (250 mg, 0.690 mmol) and TMAD (236 mg, 
1.37 mmol) in toluene (4.6 mL) was added tri-n-butylphosphine 
(342 µL, 1.37 mmol) at 0 °C. After being stirred at same 
temperature for 30 min, the resulting mixture was additionally 
stirred at room temperature for 3 h. Following to the addition of 
water, the mixture was extracted with EtOAc. The organic layer 
was washed with brine, dried over Na2SO4, and concentrated in 
vacuo. The crude product was purified by column 
chromatography (hexanes/EtOAc = 20/1 (v/v)) and 349 mg of 
ether 5 (0.446 mmol, 98%) was obtained as a colorless oil: [α]20D 
–22.3 (c 1.29, CHCl3); 1H NMR (CDCl3, 400 MHz) δ = –0.06 
(3H, s), –0.04 (3H, s), 0.86 (9H, s), 1.13 (9H, s), 1.40 (9H, s), 
1.49 (3H, s), 1.50 (3H, s), 2.20 (3H, s), 2.55 (3H, s), 3.47 (1H, dd, 
J = 10.6 and 5.0 Hz), 3.56 (1H, dd, J = 10.6 and 4.0 Hz), 4.54 
(1H, ddd, J = 10.0, 5.0 and 4.0 Hz), 4.85 (1H, d, J = 10.0 Hz), 
4.94 (1H, d, J = 11.6 Hz), 4.99 (1H, d, J = 11.6 Hz), 6.55 (1H, s), 
6.57 (1H, s), 6.78 (2H, d, J = 8.5 Hz), 7.21 (2H, d, J = 8.5 Hz), 
7.35–7.47 (6H, m), 7.71–7.77 (4H, m); 13C NMR (CDCl3, 75 
MHz) δ = –5.6, –5.5, 18.1, 19.5, 20.7, 25.8, 25.8, 26.5, 27.7, 28.4, 
29.3, 44.5, 56.7, 63.6, 70.7, 78.3, 112.7, 119.7, 127.4, 127.7, 
128.6, 129.8, 130.0, 131.0, 132.9, 135.5, 136.0, 138.5, 155.1, 
156.0, 158.7; IR (neat) 701, 835, 919, 1113, 1172, 1255, 1511, 
1610, 1700, 1721, 2858, 2930, 2957 cm–1; HRMS (ESI-TOF) m/z 
calcd for C47H68NO5Si2 ([M + H]+) 782.4636, found 782.4610. 
4.2 .2 .  (S) - t er t -butyl  [3 -{2 -([4 -{ ( ter t -
butyld iphenyls i l y l )oxy}benzyl] oxy)-4 ,6 -
d imethylphenyl} -1 -hydroxy-3-methylbu tan-2 -
yl] carbamate (6 )  
Glacial acetic acid (6.0 mL) and H2O (2.1 mL) were added to 
a solution of silyl ether 5 (298 mg, 0.381 mmol) in THF (2.1 mL). 
The reaction mixture was stirred for 9 h. After addition of water 
followed by extraction with EtOAc, the organic layer was 
washed with water and brine, dried over Na2SO4, and 
concentrated in vacuo. The crude product was purified by column 
chromatography (hexanes/EtOAc = 4/1 then 2/1 (v/v)) and 258 
mg of alcohol 6 (0.386 mmol, quant.) was obtained as a white 
amorphousness: [α]21D –6.10 (c 1.04, CHCl3); 1H NMR (CDCl3, 
400 MHz) δ = 1.11 (9H, s), 1.36 (9H, s), 1.45 (6H, s), 2.20 (3H, 
s), 2.49 (3H, s), 3.45 (1H, dd, J = 9.7 and 7.8 Hz), 3.59 (1H, d, J 
= 9.7 Hz), 4.35 (1H, dd, J = 8.5 and 7.8 Hz), 4.89 (1H, d, J = 
11.7 Hz), 4.93 (1H, d, J = 11.7 Hz), 5.05 (1H, d, J = 8.5 Hz), 
6.56 (1H, s), 6.60 (1H, s), 6.77 (2H, d, J = 8.3 Hz), 7.17 (2H, d, J 
= 8.3 Hz), 7.34–7.46 (6H, m), 7.70–7.74 (4H, m); 13C NMR 
(CDCl3, 75 MHz) δ = 19.4, 20.7, 25.9, 26.5, 28.3, 29.2, 43.5, 
59.4, 64.5, 70.9, 79.2, 112.6, 119.9, 127.6, 127.7, 129.1, 129.3, 
129.9, 130.3, 132.8, 135.5, 136.4, 138.3, 155.4, 157.3, 158.5; IR 
(KBr) 701, 823, 921, 1171, 1253, 1511, 1695, 2860, 2931, 2961 
cm–1; HRMS (ESI-TOF) m/z calcd for C41H54NO5Si ([M + H]+) 
668.3771, found 668.3797. 
4.2 .3 .  (S) -2 -([{ (9H- f luoren-9 -
yl )methoxy}carbony l] amino)-3 -{2- ([4 -{ ( ter t -
butyld iphenyls i l y l )oxy}benzyl] oxy)-4 ,6 -
d imethylphenyl} -3 -methy lbutanoic  ac id  (3 )  
To a solution of oxalyl chloride (38.0 µL, 0.444 mmol) in 
CH2Cl2 (3.6 mL) were added DMSO (63.1 µL, 0.888 mmol) and 
alcohol 6 (198 mg, 0.296 mmol) in CH2Cl2 (660 µL) slowly at –
78 °C, and the resulting solution was stirred at –40 °C for 30 min. 
After addition of triethylamine (206 µL, 1.48 mmol) followed by 
stirring for 30 min at the same temperature, the reaction mixture 
was stirred at room temperature for an additional 30 min. Then 
the reaction was quenched by the addition of water and the 
obtained mixture was extracted with CH2Cl2. The organic layer 
was washed with sat. NH4Cl aq., dried over Na2SO4, and 
concentrated in vacuo. To a solution of the crude product in 
5 
acetone/tert-BuOH/water (6/4/1 (v/v), 10 mL) were added 2-
methyl-2-butene (212 µL, 2.00 mmol), NaH2PO4 (53.3 mg, 0.444 
mmol) and NaClO2 (176 mg, 1.55 mmol). The resulting mixture 
was stirred for 2.5 h. Following to the addition of sat. NH4Cl aq., 
the mixture was extracted with EtOAc. The resulting organic 
layer was dried over Na2SO4 and concentrated in vacuo. To the 
crude product in CH2Cl2 (6.3 mL) were added 2,6-lutidine (207 
µL, 1.78 mmol) and TBSOTf (272 µL, 1.18 mmol), and the 
reaction mixture was stirred at room temperature for 2 h. The 
resulting mixture was concentrated in vacuo, and the obtained 
residue was dissolved in MeCN/10% (w/v) Na2CO3 aq. (3/1 (v/v), 
6.3 mL). To the resulting solution was added FmocOSu (120 mg, 
0.355 mmol), and the reaction mixture was stirred at room 
temperature overnight. After the addition of 5% (w/v) KHSO4 aq., 
the mixture was extracted with diethyl ether. The obtained 
organic layer was washed with brine, dried over Na2SO4, and 
concentrated in vacuo. The crude material was purified by 
column chromatography (CHCl3) and 103 mg of Fmoc derivative 
3 (0.128 mmol, 43%) was obtained as a beige amorphousness: 
[α]22D –5.58 (c 0.64, CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 
1.06 (9H, s), 1.57 (6H, s), 2.15 (3H, s), 2.47 (3H, s), 4.05–4.13 
(1H, m), 4.15 (1H, dd, J = 10.5 and 6.8 Hz), 4.28 (1H, dd, J = 
10.5 and 6.8 Hz), 4.93 (2H, s), 5.28 (1H, d, J = 9.5 Hz), 5.56 (1H, 
d, J = 9.5 Hz), 6.51 (1H, s), 6.57 (1H, s), 6.74 (2H, d, J = 8.0 Hz), 
7.18 (2H, d, J = 8.0 Hz), 7.20–7.44 (10H, m), 7.48 (1H, d, J = 7.5 
Hz), 7.67 (4H, d, J = 6.8 Hz), 7.70 (2H, d, J = 7.5 Hz); 13C NMR 
(CDCl3, 75 MHz) δ =19.4, 20.8, 25.7, 26.5, 28.3, 28.8, 44.1, 47.1, 
60.2, 66.8, 70.7, 112.5, 119.8, 119.9, 119.9, 125.1, 125.1, 127.0, 
127.6, 127.7, 128.3, 129.0, 129.4, 129.8, 132.8, 135.5, 136.9, 
137.9, 141.2, 143.9, 155.3, 156.0, 158.5, 175.6; IR (KBr) 706, 
742, 757, 823, 918, 1255, 1511, 1717, 2858, 2934, 3028 cm–1; 
HRMS (ESI-TOF) m/z calcd for C51H53NO6NaSi ([M + Na]+) 
826.3540, found 826.3577. 
4.3. Preparation of the FR traceable linker (7) 
The traceable linker was constructed on glycine preloaded 2-
chlorotrityl resin (0.87 mmol amine/g, 20 mg, 17 µmol). 
Coupling conditions for 8,20 9,21 10, and biotin: 3 eq. building 
block, 3 eq. DIC, and 3 eq. HOBt∙H2O in DMF, 2 h, room 
temperature. Coupling conditions for 3: 1.2 eq. 3, 1.2 eq. HATU, 
1.2 eq. DIEA in DMF (preactivated for 1 min), 2 h, room 
temperature. Removal of Fmoc group: 20% (v/v) piperidine in 
DMF, 2 min first treatment followed by washing and subsequent 
second treatment for 8 min, room temperature. Cleavage from 
resin (20 mg): TFE/AcOH/CH2Cl2 (1/1/3 (v/v)), 1 mL, 2 h, room 
temperature. Work-up: After removal of solvent under vacuo, 
MeCN/H2O (1/1 (v/v)) was added to the resulting mixture. 
Following the removal of the resin by filtration, the solution was 
subjected to HPLC purification to yield traceable linker 7 as a 
white lyophilized powder (2.6 mg, 12%). Analytical HPLC 
conditions: linear gradient of solvent B in solvent A, 50 to 90% 
over 30 min. Retention time = 24.3 min. Semi-preparative HPLC 
conditions: linear gradient of solvent B in solvent A, 50 to 90% 
over 30 min. LRMS (ESI-Ion Trap) m/z calcd for 
C62H85N10O13SSi ([M + H]+) 1237.6, found 1237.2. 
4.4. Click chemistry of traceable linker with model peptide (12) 
To a solution of traceable linker 7 (0.1 µmol) and peptide 11 
(0.1 µmol) in H2O/tert-BuOH (1/1 (v/v), 100 µL) were added 
CuSO4∙H2O (0.06 µmol) and sodium ascorbate (0.5 µmol), and 
the reaction mixture was shaken at room temperature for 1 h. 
Reaction progress was monitored by analytical HPLC. Analytical 
HPLC conditions: linear gradient of solvent B in solvent A, 5 to 
90% over 30 min. Conjugate 12: retention time = 23.1 min. 
LRMS (ESI-Ion Trap) m/z calcd for C101H142N24O21SSi ([M + 
2H]2+) 1043.5, found 1043.2. 
4.5. Fluoride-induced cleavage of the traceable linker followed 
by labeling (13-16) 
Peptide-traceable linker conjugate 12 (0.1 µmol) in phosphate 
buffer containing 6 M guanidine hydrochloride and 0.05 mM 
EDTA (200 mM phosphate, pH 7.6, 100 µL) was treated with KF 
(10 µmol) and MESNa (10 µmol). After incubation at 37 °C for 
12 h, 3-bromobenzaldehyde (0.1 µmol) was added to the reaction 
mixture. Progress of the reaction was monitored by HPLC. 
Analytical HPLC conditions: linear gradient of solvent B in 
solvent A, 5 to 90% over 30 min. Intermediate 13: retention time 
= 16.5 min, LRMS (ESI-Ion Trap) m/z calcd for C85H123N24O21S 
([M + H]+) 1847.9, found 1847.3. Biotin derivative 14: retention 
time = 20.2 min, LRMS (ESI-Ion Trap) m/z calcd for 
C29H43N4O7S ([M + H]+) 591.3, found 591.1. Aminooxy 
derivative 15: retention time = 11.2 min, LRMS (ESI-Ion Trap) 
m/z calcd for C49H75N20O13 ([M + H]+) 1151.6, found 1151.2. 
Labeled derivative 16: retention time = 15.4 min, LRMS (ESI-
Ion Trap) m/z calcd for C56H78BrN20O13 ([M + H]+) 1317.5 (71Br 
derivative) and 1319.3 (81Br derivative), found 1317.1 and 1319.3. 
4.6. Preparation of siloxybenzyl chloride 17 
 
 
Scheme 3. Reagents and conditions: (i) SOCl2, CH2Cl2, 70%. 
 
Thionyl chloride (0.80 mL, 11 mmol) was slowly added to a 
solution of alcohol 417 (2.0 g, 5.2 mmol) in CH2Cl2 (12 mL) at 
0 °C, and the solution stirred for 2 h at room temperature. After 
the addition of ice, the reaction mixture was extracted with 
EtOAc. The organic layer was washed with saturated aqueous 
solution of NaHCO3 followed by brine, dried over MgSO4, and 
concentrated in vacuo. Chloride 17 was obtained as a white solid 
(1.4 g, 70%) and was used without further purification. mp 77–
79 °C; 1H NMR (CDCl3, 400 MHz) δ = 1.09 (9H, s), 4.48 (2H, s), 
6.73 (2H, d, J = 8.5 Hz), 7.11 (2H, d, J = 8.5 Hz), 7.34–7.45 (6H, 
m), 7.68–7.72 (4H, m); 13C NMR (CDCl3, 75 MHz) δ = 19.4, 
26.2, 26.4, 46.2, 119.8, 127.8, 129.7, 129.9, 132.6, 135.4, 155.6; 
IR (KBr) 704, 919, 1115, 1258, 1510, 1605, 2858, 2932, 2960, 
3070 cm–1; HRMS (ESI-TOF) m/z calcd for C23H26OSiCl ([M + 
H]+) 381.1441, found 381.1457; Anal. calcd for C23H25OSiCl: C, 
6.61; H, 72.51. Found: C, 6.63; H, 72.39. 
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Figure 4. Fluoride-induced cleavage of the traceable linker followed by selective labeling. (a) Treatment of the traceable linker-peptide conjugate 12 with KF 
followed by labeling with 3-bromobenzaldehyde. (b) HPLC monitoring of the reactions. HPLC conditions: Cosmosil 5C18-AR-II analytical column, linear 
gradient of 0.1% (v/v) TFA/MeCN in 0.1% (v/v) TFA aq., 5–90% over 30 min.*Non-peptidic compound derived from the quinone methide.24 **3-
Bromobenzaldehyde. 
